Impax Laboratories

Impax Laboratories, Inc. is a technology-based specialty pharmaceutical company. The company is dedicated to the development and commercialization of bioequivalent generic drugs and branded drugs. In the generic drug market, the company focuses on controlled-release versions of brand-name drugs, covering a range of therapeutic areas. In the branded pharmaceuticals market, the company is developing products for the treatment of central nervous system disorders. The company's branded product portfolio includes projects in the development stage, utilizing its formulation and development expertise to create differentiated, modified, or controlled-release versions of existing marketed drugs. It is divided into two segments: the Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceuticals Division (Impax Division).